Maravai LifeSciences (MRVI)
(Delayed Data from NSDQ)
$8.29 USD
+0.03 (0.36%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $8.28 -0.01 (-0.12%) 5:16 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Maravai LifeSciences Holdings, Inc. (MRVI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$11.00 | $17.00 | $7.00 | 33.17% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for Maravai LifeSciences Holdings, Inc. comes to $11.00. The forecasts range from a low of $7.00 to a high of $17.00. The average price target represents an increase of 33.17% from the last closing price of $8.26.
Analyst Price Targets (11)
Broker Rating
Maravai LifeSciences Holdings, Inc. currently has an average brokerage recommendation (ABR) of 1.58 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms. The current ABR compares to an ABR of 1.58 a month ago based on 13 recommendations.
Of the 13 recommendations deriving the current ABR, eight are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 61.54% and 15.38% of all recommendations. A month ago, Strong Buy made up 61.54%, while Buy represented 15.38%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 7 | 7 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.58 | 1.58 | 1.58 | 1.63 | 1.63 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/8/2024 | Goldman Sachs | Matthew Sykes | Hold | Hold |
9/3/2024 | KeyBanc Capital Markets | Paul Knight | Hold | Hold |
8/27/2024 | Wells Fargo Securities | Brandon Couillard | Not Available | Strong Buy |
8/8/2024 | William Blair | Matt Larew | Strong Buy | Strong Buy |
8/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/8/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
8/8/2024 | UBS | Dan Leonard | Not Available | Hold |
5/9/2024 | Robert W. Baird & Co. | Catherine W Schulte | Strong Buy | Strong Buy |
4/10/2024 | Craig-Hallum | Christian D Schwab | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.58 |
ABR (Last week) | 1.58 |
# of Recs in ABR | 13 |
Average Target Price | $11.00 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 62 of 252 |
Current Quarter EPS Est: | 0.00 |
MRVI FAQs
Maravai LifeSciences Holdings, Inc. (MRVI) currently has an average brokerage recommendation (ABR) of 1.58 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms.
The average price target for Maravai LifeSciences Holdings, Inc. (MRVI) is $11.00. The current on short-term price targets is based on 6 reports.
The forecasts for Maravai LifeSciences Holdings, Inc. (MRVI) range from a low of $7 to a high of $17. The average price target represents a increase of $33.17 from the last closing price of $8.26.
The current UPSIDE for Maravai LifeSciences Holdings, Inc. (MRVI) is 33.17%
Based on short-term price targets offered by 11 analysts, the average price target for Maravai LifeSciences Holdings, Inc. comes to $11.00. The forecasts range from a low of $7.00 to a high of $17.00. The average price target represents an increase of 33.17% from the last closing price of $8.26.